LIST OF WITNESSES TO APPEAR BEFORE
COMMITTEE ON WAYS AND MEANS
ON INTEGRATING PRESCRIPTION DRUGS INTO MEDICARE

WEDNESDAY, APRIL 17, 2002 - BEGINNING AT 10:30 A.M.
ROOM 1100 LONGWORTH HOUSE OFFICE BUILDING

Opening Statements:

• The Honorable Bill Thomas, M.C., California, Chairman
• The Honorable Charles B. Rangel, M.C., New York, Ranking Minority Member
• The Honorable Jim Ramstad, M.C., Minnesota
• The Honorable Jim Nussle, M.C., Iowa
• The Honorable Mark Foley, M.C., Florida

The Honorable Tommy G. Thompson, Secretary,  U.S. Department of Health and Human Services

The Honorable David M. Walker, Comptroller General of the United States, U.S. General Accounting Office

PANEL:

Bruce E. Bradley, Director, Health Plan Strategy and Public Policy, General Motors Corporation, Detroit, Michigan

Raymond V. Gilmartin, Chairman, President and Chief Executive Officer, Merck & Co., Inc., Whitehouse Station, New Jersey

William D. Novelli, Executive Director and Chief Executive Officer, AARP

John M. Rector, Senior Vice President, Government Affairs and General Counsel, National Community

Mitchel Sayare, Ph.D., Chairman and Chief Executive Officer, ImmunoGen, Inc., Cambridge, Massachusetts